Key result
Manual thrombus aspiration with the Export catheter yielded similar 3-year rates of cardiac death, recurrent MI, or TVR compared to the X-sizer system (22.2% vs 18.6%; HR 1.20; P=0.35).
Why the study?
Does manual thrombus aspiration with the Export catheter improve clinical outcomes compared to mechanical thrombus cutting/aspiration with the X-sizer system in patients undergoing PPCI for STEMI?
RCT (n=201)
Does manual thrombus aspiration with the Export catheter improve clinical outcomes compared to mechanical thrombus cutting/aspiration with the X-sizer system in patients undergoing PPCI for STEMI?
Hazard Ratio: 1.2 (95% CI 0.65–2.22)
Absolute Event Rate: 22.2% vs 18.6%
p-value: p=0.35
Manual thrombus aspiration and mechanical thrombus cutting/aspiration yielded similar 3-year clinical outcomes in patients undergoing primary PCI for STEMI.
OBJECTIVES: The objective of this study was to compare the efficacy and long-term clinical outcome of manual thrombus aspiration with the Export catheter (Medtronic, Minneapolis, MN) versus mechanical thrombus cutting/aspiration with the X-sizer system (eV3, White Bear Lake, MN) in primary percutaneous coronary intervention (PPCI). BACKGROUND: In PPCI for acute ST-segment elevation myocardial infarction (STEMI), markers of myocardial reperfusion are improved with adjunctive thrombectomy. Previous studies of different devices showed a variability in performance, suitability, and short-term clinical outcome. In current literature, no direct comparison is available. METHODS: We prospectively randomized 201 patients admitted for PPCI for STEMI to either the Export catheter or the X-sizer prior to stent deployment. Technical success in advancing to and across the lesion, improvement of flow, reduction of thrombus, and the effect on ST-segment resolution were examined. The primary endpoint of the follow-up study was the combined endpoint of cardiac death, recurrent myocardial infarction (MI), or target-vessel revascularization (TVR) at 3 years. RESULTS: Although the Export catheter was more successfully deployed, other procedural parameters were similar with a trend toward better ST-segment resolution (56.6% vs. 44%; P = 0.06) as compared to the X-sizer system. The occurrence of the primary clinical endpoint at 3 years was 22.2% and 18.6%, respectively (HR 1.20; 95% CI 0.65-2.22; P = 0.35). CONCLUSION: Despite shorter procedural times, better lesion crossing, and fewer complications, both surrogate endpoints as well as 3-year clinical follow-up were similar with the use of the Export catheter as compared to the X-sizer system.
No takes yet. Share an insight, caveat, or question.
Vink et al. (2011) conducted an RCT in ST-segment elevation myocardial infarction (STEMI) (n=201). Manual thrombus aspiration with the Export catheter vs. Mechanical thrombus cutting/aspiration with the X-sizer system was evaluated on Combined endpoint of cardiac death, recurrent myocardial infarction (MI), or target-vessel revascularization (TVR) at 3 years (HR 1.20, 95% CI 0.65-2.22, p=0.35). Manual thrombus aspiration with the Export catheter yielded similar 3-year rates of cardiac death, recurrent MI, or TVR compared to the X-sizer system (22.2% vs 18.6%; HR 1.20; P=0.35).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: